International Journal of Tuberculosis and Lung Disease 2013-09-01

Novel pediatric delivery systems for second-line anti-tuberculosis medications: a case study.

J Furin, G Brigden, E Lessem, M C Becerra

Index: Int. J. Tuberc. Lung Dis. 17(9) , 1239-41, (2013)

Full Text: HTML

Abstract

Tens of thousands of children are sick with multidrug-resistant forms of tuberculosis (MDR-TB), but there are limited child-friendly delivery systems for second-line medications. This case study presents the development of a granular dosing spoon pediatric delivery system for para-aminosalicylic acid. This product is the first of its kind for MDR-TB and could serve as a model for the development of other urgently needed pediatric delivery systems for second-line anti-tuberculosis drugs.